Introduction
Members of the superfamily of GTP-binding (G) proteins play a critical role in transducing external stimuli to downstream signaling cascades (Bourne et al., 1990; Neer and Clapham, 1988; Simon et al., 1991) . G12 class is comprised of two pertussis toxininsensitive G-proteins, Ga12 and Ga13, that were originally isolated by subjecting mouse complementary DNA (cDNA) to the degenerate-polymerase chain reactions (PCR) (Strathman and Simon, 1991) . Using an expression cDNA cloning-strategy, we isolated the human wild-type Ga12 cDNA in the NIH3T3 focus forming assay as a transforming sequence (Chan et al., 1993) , thereby de®ning an initial biological activity for this novel G-protein.
Mutations introduced into Ga12 and Ga13 that correspond to those that activate Ras induce potent morphological and malignant transformation of rodent ®broblasts Xu et al., 1993 Xu et al., , 1994 , raising the possibility that Ga12 may play a role in human cancer. Although the physiological role of Ga12 remains to be determined, growing evidence suggests that it participates in multiple cellular functions. Thyrotropin, a primary hormone regulating thyroid cell functions is shown to stimulate the uptake of photoreactive GTP analogue into immunoprecipitated Ga12 (Laugwitz et al., 1996) . Similarly, in human platelet, Ga12 has been shown to be activated via thromboxane A2 and thrombin receptors and may therefore be involved in platelet activation (Oermans et al., 1994) . By analogy, Ga12 is also required for thrombin-stimulated gene expression and mitogenesis in 132N1 astrocytoma cells (Aragay et al., 1995) . Finally, the GTPase-de®cient mutant of Ga12 when transiently transfected into COS-1 cells, stimulates the amiloride-sensitive Na + /H + ion exchanger (NHE) (Dhanasekaran et al., 1994) in a protein kinase C (PKC)-dependent fashion indicating Ga12 may play a role in regulating intracellular pH and cell volume.
Emerging evidence also links Ga12 to signaling pathways initiated from other GTPases belonging to the RAS and RHO gene families, ®ndings that provide insights into the downstream signaling events of Ga12. First, in Ga12-transformed Rat-1 cells, an increase in MAPK activity in response to epidermal growth factor (EGF) was observed , suggesting that the Ras-Raf-MAPK pathway may be perturbed by Ga12. Activated Ga12 is not sucient to stimulate MAPK activity (Prasad et al., 1995; Zhang et al., 1996; Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) . Instead, Ga12 has been reported to activate a distinct MAPK pathway, the c-Jun N-terminal kinase (JNK) pathway that normally mediates signals induced by stress, cytokines, and growth factors (Prasad et al., 1995; Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) . The fact that two members of the RHO gene family, Rac1 and Cdc42Hs, have been implicated as the upstream activators of JNK (Coso et al., 1995) , raises the possibility that Ga12-induced biological responses are mediated by RHO gene family members. Further support of this hypothesis is provided by the observation that a RhoA-dependent induction of stress ®bers and focal adhesion complex formation when Ga12 is microinjected into serum-starved Swiss 3T3 cells (Buhl et al., 1995) , implying that Ga12 has a role in regulating the actin cytoskeleton. Finally and indirectly, Ga13 induction of NHE activity can be blocked by dominant negative mutants of Cdc42Hs and RhoA (Hooley et al., 1996) . Intriguingly, several of the biological functions ascribed to Ga12 can also be blocked by a dominant negative mutant of Ras; these include JNK activation (Prasad et al., 1995; Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) and thrombin stimulation of 132N1 astrocytoma cells (Aragay et al., 1995) . All these data implies that Ga12 induced biological responses require the participation of several G-protein mediated signaling cascades, with members of the RHO gene family being more intimately involved. However, the contribution of JNK activation, NHE activity, stress ®bers and focal adhesion complex formations in cellular transformation is by far unclear.
The RHO gene family is composed of members (RhoA, RhoB, RhoC, RhoE, RhoG, Rac1, Rac2, Cdc42Hs, TC10 and TTF) that are distantly related to the p21 Ras protein. Cumulating evidence mainly derived from microinjection studies has linked the Rho proteins to cytoskeletal organization. In general, RhoA is implicated in the formation of stress ®bers and focal adhesions Nobes and Hall, 1995) ; Rac1 mediates the appearance of membrane rues and lamellipodia formation ; and Cdc42Hs is believed to regulate ®lopodia assembly (Nobes and Hall, 1995) . In addition, constitutively active GTPase-de®cient mutants of these three G-proteins were demonstrated to promote G1 to S phase transition during cell cycle and DNA synthesis when microinjected into serum-starved ®broblasts (Olson et al., 1995) . However, only the GTPase-de®cient mutants of Rac1, RhoA and RhoB have so far been shown to induce weak transforming activity in rodent ®broblasts (Qiu et al., 1995a,b; Prendergast et al., 1995) . Given the intimate relationship between Ga12-elicited biological responses and RHO gene members, we report here the selective cooperation between Ga12 and members of the RHO gene family in inducing transformation in NIH3T3 cells.
Results

Selective inhibition of Ga12 transformation by dominant negative mutants of RHO gene family members
Previous studies using dominant inhibitory Asparagine 17 (Asn 17) mutants of both RhoA and Rac1 have demonstrated their roles in Ras transformation (Qiu et al., 1995a,b; Prendergast et al., 1995) . To assess the involvement of RHO gene members in the transforming signaling of Ga12 oncogene, co-transfection experiments were performed using dominant negative mutants of Rac1, RhoA and Cdc42Hs to test their relative ability in inhibiting a GTPase-de®cient mutant of Ga12 (Ga12 Leu 229) in inducing transformation in NIH3T3 cells. For these experiments, the amount of Ga12 mutant plasmid was titrated to give *100 foci per plate (*20 ng) and co-transfected with either 600 ng of control vector (pCEV29-LacZ'/Neo) or equal amounts of the dominant negative mutant constructs (Rac1 Asn 17, RhoA Asn 19, and Cdc42Hs Asn 17). As shown in Figure 1 , dominant negative mutants of the RHO gene family members displayed dierential eects on Ga12 transformation with Rac1 Asn 17 showing *60% inhibitory activity, followed by RhoA Asn 17 (*30%). In addition, the remaining foci in plates transfected with Rac1 Asn 17 showed a substantial reduction in size when compared to that transfected with RhoA Asn 19 (data not shown). In contrast, Cdc42Hs Asn 17 failed to produce any signi®cant inhibitory eect on Ga12 transformation. These data led us to conclude that both Rac1 and RhoA play a role in the transformation induced by Ga12 by potentially conferring enhanced morphological or proliferative properties to Ga12-transformed cells.
Ga12 cooperates with Rac1 Val 12 mutant in transforming NIH3T3 cells
To further investigate the role of Rho GTPases in Ga12 transformation, we have examined the relative ability of constitutive active mutants of Rac1, RhoA, and Cdc42Hs in promoting the transforming capacity of Ga12 in NIH3T3 cells. For this, we co-transfected wild-type Ga12 (Ga12 wt) separately with GTPasede®cient mutants of RhoA (RhoA Leu 63), Rac1 (Rac1 Val 12) and Cdc42Hs (Cdc42Hs Val 12) in NIH3T3 cells. The use of the wild-type but not the GTPasede®cient version of Ga12 in these experiments was due to the lower speci®c transforming activity of the wildtype Ga12 versus the activated mutant expression vector. The necessity to use greater amounts of Ga12 Figure 1 Inhibition of Ga12 transformation by dominant negative RHO mutants. NIH3T3 cells were co-transfected with Ga12 Leu 229 oncogenic mutant together with dominant inhibitory mutants of Rac1, RhoA, or Cdc42Hs. Parallel cultures were transfected with equal amount of control vector, pCEV29-LacZ'. For these studies, the amount of DNA used for each plasmid is indicated, and the number of foci induced in control plate are *100. Results represent average values from duplicated plates and were derived from three independent experiments wt plasmids would promote the co-transfection eciency with RHO mutant plasmids and thereby enhancing the detection of any synergistic eects. All plasmids were adjusted to give a low focus-forming activity (520) for each transfected culture plate. As shown in Figure 2a and summarized in Table 1 whereas Ga12 wt or Rac1 Val 12 alone when cotransfected with control plasmid yielded 12 and 17 foci, respectively; co-transfecting equivalent amounts of Ga12 wt and Rac1 Val 12 produced an average of 7.8-fold increase in the number (*113 foci) of transformed foci. The resulting foci were larger in size and appeared much earlier (7 days) than if these two expression plasmids were transfected alone ( Figure 2b ). In contrast, when Ga12 wt and RhoA Leu 63 expression plasmids were co-transfected under similar conditions, only an additive eect (twofold) was observed. Given the fact that the transforming eciency of Rac1 Val 12 is *2-fold higher than RhoA Leu 63, the normalized speci®c activity of Rac1 mutant in cooperating with Ga12 wt was therefore *4-fold higher than that of RhoA mutant. These data were reproducibly produced in two separate experiments with essentially similar results (Table 1) . c-raf-1 has previously been shown to cooperate with both Rac1, RhoA, and RhoB mutants in transforming NIH3T3 cells (Qiu et al., 1995a,b; Prendergast et al., 1995) . To further con®rm the observed synergistic eect was not due to dierences in co-transfection eciency displayed by Rac1 Val 12 and RhoA Leu 63, both plasmids were co-transfected with c-raf-1 expression construct as a separate independent control. As shown in Table 1 , both Rac1 Val 12 and RhoA Leu 63 mutants synergized with c-raf-1 resulting in an approximatley 14-and 30-fold increase in the number of transformed foci, respectively. As expected, wild-type Ga12 also cooperated with c-raf-1 in the same experiment. These results suggested that the observed synergistic transformation between Ga12 wt and Rac1 Val 12 was speci®c and potentially indicate a functional cooperation in their downstream signaling events. We further examined in detail the resulting focus morphology induced in the co-transfection experiments. Ga12 wt-induced foci were typi®ed by an overall stellate appearance with high cell density in the center of the focus (Chan et al., 1993). In contrast, Rac1 Val 12 induced focus morphology was completely dierent from those of Ga12 with an unique elongated pattern of high cell density (Figure 2b ). Interestingly, NIH3T3 cells co-transfected with Ga12 wt and Rac1 Val 12 displayed morphology of mixed phenotypes characterized by features unique to both (Figure 2b ). These observations raised the possibility that alterations in cytoskeletal organization leading to the respective transformed morphology of Ga12 and Rac1 are of co-dominance in nature, implying the potential divergence in their signaling pathways controlling cell shape. Furthermore, the eect of cotransfecting c-raf-1 appeared to result in the promotion of the respective transformed morphology induced by Ga12 wt, Rac1, and RhoA mutants. In this case, both Ga12 wt and RhoA Leu 63 foci induced by cotransfecting with c-raf-1 were almost indistinguishable (data not shown). In contrast, morphology of Rac1 Val 12+c-raf-1 co-transfected foci were completely distinct. We conclude from these observations that Ga12 and RhoA may evoke common downstream eectors responsible for their shared cell morphology which are distinct from that of Rac1.
Lack of inhibition by C3 ADP-ribosyl transferase exoenzyme on mitogenic response induced by mutant Ga12
It is paradoxical that the dominant inhibitory mutant of RhoA blocked Ga12 transformation, while Ga12 and RhoA failed to cooperate in transforming NIH3T3 cells. To clearly de®ne the role of RhoA in Ga12-induced transforming signaling, we examined the eect of a speci®c inhibitor of RhoA, C3 transferase, on one of the biological properties of transformation, enhanced DNA synthesis. C3 transferase is a toxin produced by the bacterium, Clostridium Botulinum, which speci®cally ribosylates an asparagine residue at position 41 (Asn 41) within the RhoA eector-binding site domain, and thereby inhibiting its interaction with downstream substrates (Sekine et al., 1989) .
As shown in Figure 3 , DNA synthesis of NIH3T3 cells transfected with control vector showed a dosedependent decrease in [ 3 H]thymidine incorporation displaying a 70% inhibition in mitogenesis at the maximal concentration of 27 mg ml
71
. The doseresponse curve was consistent with the earlier ®nding using Swiss 3T3 cells in which a 50% growth inhibition was achieved at 10 mg ml 71 within 2 days of treatment (Yamamoto et al., 1993) . Under similar experimental conditions, NIH3T3 cells transformed by Ga12 mutant, which exhibited elevated levels of mitogenicity when compared to control cells, were not substantiallay inhibited by C3 transferase, retaining *80% of the ability to induce DNA synthesis when compared to untreated cells at the highest C3 concentration ( Figure  3 ). Similar result was also obtained with cells overexpressing a constitutively active mutant of Rac1. We conclude from these observations that RhoA did not play a signi®cant role in the mitogenic stimulation induced by Ga12 in NIH3T3 cells.
Eects of co-expressing Ga12 and Rac1 on JNK kinase, activity
Activated forms of both Ga12 and Rac1 have been shown to stimulate the activity of JNK (Prasad et al., Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) , a kinase implicated in stress response signaling resulted in the activation of downstream c-Jun transcriptional activity. To examine whether the observed synergistic transformation induced by wildtype Ga12 and the activated mutant of Rac1 was due to the cooperative activation of this kinase cascade, transient co-transfection and subsequent analysis of the kinase activity of a hemagglutinin (HA) epitope-tagged of JNK (HA-JNK) was performed in COS7 cells. The kinase substrate used in these analyses was provided by a 38 kDa GST-fusion protein containing the Nterminal 79 amino acid of c-Jun. Transient transfection in COS7 cells provided the advantages of high levels of co-transfection eciency and gene expression, and is also represented a more controlled assay system due to the potential presence of adaptive responses when similar assays were to be performed in stablytransformed NIH3T3 cells. As shown in Figure 4 and consistent with results derived from previous studies (Prasad et al., 1995; Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) , Ga12 Leu 229 mutant stimulated the kinase activity of HA-JNK by *4.0-fold whereas the wild-type Ga12 produced a weaker response of 2.0-fold. In contrast, whereas the wild-type Rac1 produce a modest eect (3.7-fold) on HA-JNK activity, Rac1 Val 12 mutant displayed a robust stimulation of HA-JNK by *11.0-fold. As control, a constitutively active upstream stimulator of JNK, MEKKE1, stimulated the HA-JNK activity by more than 25.0-fold. In order to correlate with the data derived from focus forming assay in NIH3T3 cells, we have co-transfected Ga12 wt with Rac1 Val 12 mutant and have observed a *20.0-fold induction of JNK activity. This magnitude of stimulation is 1.5-fold higher than the additive eect (13.0-fold) of when Ga12 wt and Rac Val 12 were transfected alone. In contrast, co-transfecting wild-type versions of Rac1 with Ga12 did not result in any signi®cant enhancement in the HA-JNK kinase activity. In addition, co-transfecting wild-type Ga12 with the activated RhoA Leu 63 mutant failed to produce any further activation of HA-JNK activity (data not shown). We conclude from these data that the co-expression of Ga12 wt and Rac1 Val 12 mutant resulted in a weak synergistic eect in stimulating JNK activity in COS7 cells.
Activation of transcription from serum response element (SRE) by co-expressing Ga12 and Rac1
Previous studies have demonstrated that activation of the serum response element (SRE) in the c-fos promoter region required the assembly of both serum response factor (SRF) and ternary complex factor (TCF) for maximal transcriptional activation (Hill et al., 1995) . TCF activity is regulated by phosphorylation events propagated from the Ras-Raf-MAPK cascade. On the contrary, SRF activity could be separately activated through a RhoA-dependent or a Rac1/ Cdc42Hs-dependent pathway. RhoA in this case is presumably activated in response to the stimulation of G-protein coupled receptors through a-subunit of heterotrimeric G-proteins.
To assess whether the observed synergistic transformation between Ga12 and Rac1 was associated with the simultaneous activation of SRF, we measured the transcriptional responses in NIH3T3 cells using a response element consisting of three tandem copies of the SRE fused upstream to a cassette containing a c-fos minimal promoter and a luciferase reporter gene. For co-transfection experiments, both Ga12 and Rac1 mutant expression plasmids were ®rst titrated to give *2 ± 3-fold increase in transcriptional activity ( Figure  5a ). The use of the constitutive active mutant of Ga12 in these studies was due to the requirement of prolonged (*24 h) low-serum (0.5% CS) growth prior to reporter assays, conditions that would render the wild-type Ga12 molecule inactive. When equivalent amounts of mutant Ga12 and Rac1 expression plasmids were transiently co-transfected in NIH3T3 cells, an eightfold increase in SRE transcriptional activity level was 2.4-fold higher than the additive eect of when Ga12 Leu 229 and Rac Val 12 mutants were transfected alone (Figure 5a ). In contrast, cotransfecting Ga12 expression plasmids with RhoA Leu 63 activated mutant did not result in a further increase in SRE responses (Figure 5b ). This lack of cooperativity was also observed when Ga12 was co-transfected with activated mutant of Cdc42Hs (data not shown). We conclude from all these data that the selective synergistic transformation between Ga12 and Rac1 correlated with their cooperative activation of SRE transcriptional events.
Discussion
There is ample evidence suggesting members of the RHO gene family of small GTPases in mediating Ga12 induced biological responses. For instance, the ability of Ga12 in inducing stress ®ber and focal adhesion complex formation in quiescent Swiss 3T3 cells could be abrogated by C3 transferase implying a Rhodependent event (Buhl et al., 1995) . Secondly, the ability of activated Ga12 mutant in stimulating JNK/ SAPK activity in HEK293, COS1, NIH3T3, and HeLa cells could be inhibited by a dominant negative Rac1 mutant (Rac1 Asn 17) (Collins et al., 1996) ; and that Figure 5 Synergistic activation of SRE transcription by Ga12 and Rac1. The relative ability of Ga12 Leu 229 activated mutant in stimulate transcription from SRE when cotransfected with either a constitutively active mutant of Rac1 (a) or RhoA (b) was measured by transient co-transfecting NIH3T3 cells at the indicated amounts of expression plasmids. To measure the transcriptional activity, each plate was co-transfected with 2.0 mg of a reporter plasmid, SRE-Luc, which contains three tandem SRE elements fused upstream of a luciferase reporter gene. Approximately 18 h after transfection, cultures were serum-deprived for 24 h and cells were solubilized with 200 ml of reporter lysis buer (Promega). Around 20 ml of each cell lysate was used to assess the levels of luciferase activity with the addition of 100 ml of the substrate, luciferin (470 mM), and the amount of light emitted was measured on a luminometer. Results are expressed as arbitrary luminescence unit normalized with the amount of total protein being used in each assay. Results represent averaged values derived from duplicated plates from a single experiment and have been repeated in two additional experiments with similar results being obtained. Abbreviation: CS, calf serum the expression of a dominant negative Cdc42 mutant blocks Ga12 induced JNK/SAPK activity in COS7 cells (Voyno-Yasenetskaya et al., 1996) . Finally, and indirectly, Ga13 stimulates NHE activity were both RhoA-and Cdc42Hs-dependent (Hooley et al., 1996) .
The data presented in this report provides evidence that cellular transformation induced by Ga12 in NIH3T3 cells showed a dierential dependency on members of the RHO gene family. Based on the relative potency of dierent dominant negative mutants in inhibiting Ga12-induced transformation, Rac1 seems to play a greater role in the transforming signaling of Ga12 than RhoA or Cdc42Hs in NIH3T3 cells. This is also re¯ected in the substantial enhancement of cellular transformation when wild-type Ga12 and Rac1 Val 12 were co-transfected into NIH3T3 cells. In contrast, cotransfecting wild-type Ga12 and RhoA Leu 63 mutant plasmids under similar experimental conditions only resulted in an additive eect.
The inability of activated mutant of RhoA in cooperating with Ga12 in either transforming NIH3T3 cells or to stimulate SRE transcriptional responses implying that RhoA may not play a major role in the proliferative signaling of Ga12-transformed cells. This interpretation is strengthened by the observation that the RhoA-speci®c inhibitor, C3 ribosyltransferase, has minimal eect on the mitogenesis of Ga12 transformed NIH3T3 cells. Interestingly, Buhl et al. have reported that C3 could inhibit the ability of Ga12 in promoting stress ®ber formation and focal adhesions assembly in Swiss 3T3 cells implying a role of RhoA in conferring cytoskeletal organization in Ga12 expressing cells. The modest level (*30%) of inhibitory eect displayed by RhoA dominant negative mutant on the transforming potential of Ga12 may well be explained by the disruption of the Ga12-induced morphological changes in NIH3T3 cells. Based on all these observations and cumulated with the ®ndings that both RhoA-and Ga12-induced transformed foci are morphologically indistinguishable, led us to speculate that RhoA may play a role in the morphological features characteristic of Ga12-transformed foci. We are currently addressing this possibility by examining whether Ga12 can activate certain Rho downstream targets, such as ROKs (Leung et al., 1995) .
The signi®cant synergistic eect observed between Ga12 and Rac1 Val 12 mutant may re¯ect the cooperative activation of downstream signaling targets resulted in the observed increase in proliferation and the distinct morphological transformation displayed by the co-transfectants. The JNK/SAPK pathway has been frequently implicated in stress-induced signaling and the constitutive activation of this pathway has been reported to induce programmed cell death in Rat1 ®broblasts (Johnson et al., 1996) . Both Ga12 and Rac1 Val 12 have been reported to activate JNK/SAPK activity in several cell lines (Prasad et al., 1995; Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) . However, co-expression of both in COS7 cells resulted in only a weak synergistic eect, whereas in the same experiment, MEKK, which is an upstream activator of JNK/SAPK, resulted in a 27.0-fold increase in c-Jun phosphorylation. More recently, using a panel of Rac1 eector-binding site mutants, Rac1-induced cellular transformation, and membrane ruing have been demonstrated to be dissociated from its ability to stimulate JNK/SAPK activity (Joneson et al., 1996) . We are currently testing whether Ga12 could cooperate with these Rac1 eector-loop mutants in transforming NIH3T3 cells in an eort to ascertain the importance of JNK/SAPK in Ga12-mediated cellular transformation.
One biological response which shows considerable correlation with the observed synergistic transforming eects is the transcriptional stimulation of the SRE. Previous studies have delineated a RhoA-dependent and a Rac1/Cdc42Hs-dependent parallel pathways in the activation of SRE through the phosphorylation of SRF (Hill et al., 1995) . The ability of Ga12 in further stimulating SRE transcription when co-transfected with the activated Rac1 mutant may imply the presence of a Rac1-independent pathway utilized by Ga12 in activating SRF. The inability of Ga12 in inducing the MAPK cascade (Prasad et al., 1995) most likely ruled out the possibility of Ga12 in stimulating TCF activity and thereby cooperates with SRF in activating SRE transcription. Instead, we speculate that RhoA or RhoA-like GTPases may serve as potential candidates in mediating the observed synergistic eect.
Based on all these ®ndings, Ga12 transformation could be broadly viewed as the collective perturbation of both proliferative and morphological events involving the Rac1-and RhoA-dependent signaling cascades, respectively. Similar scenario has been described for Ras transformation in which Rac1, RhoA and RhoB have been shown to play important roles (Qiu et al., 1995a,b; Prendergast et al., 1995) . Evidence pertaining to the ability of Ga12 in directly activating the GTP-loadings of Rac1, RhoA and Cdc42Hs is still limiting. It is therefore uncertain whether the observed functional interactions between Ga12 with Rac1 and RhoA represent events involving the same or distinct pathways. Eorts in identifying and isolating the immediate downstream substrates for Ga12 would, therefore, be highly warranted.
Materials and methods
Plasmids
Most plasmids used in this study have been described previously: pCEV27-Ga12 wild-type, pCEV27-Ga12 Leu 229 (Zhang et al., 1996) ; pCEV29-Rac1 Asn 17, pCEV29-RhoA Asn 19, pCEV29-Cdc42Hs Asn 17, pCEV29-Rac1 Val 12, pCEV29-RhoA Leu 63, pCEV29-Cdc42Hs Val 12, pCDNAIII-HA-JNK and pGEX-Jun79 (Coso et al., 1995) .
For pCDNAIII-Ga12 expression construct used in transient transfection experiments, a 1.4 kb BamHI fragment containing the entire coding region of Ga12 Leu 229 mutant (Chan et al., 1993; Zhang et al., 1996) was subcloned into the BamHI cloning site of pCDNAIII vector.
Cell cultures
The NIH3T3 cell line was established in this laboratory. The COS7 cells were purchased from American Type Culture Collection (ATCC). Transfection was carried out using the standard calcium phosphate precipitation method (Wigler et al., 1977) and all cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% calf serum (CS). Culture dishes used for mitogenicity, and SRE assays were pre-coated with ®bronectin (UBI, 10 mg ml 71 ) for 1 h at 378C.
Antibodies
The monoclonal antibody directed against HA-epitope was provided by Dr T Moran at the Mt Sinai Monoclonal Core Facility.
NIH3T3 focus forming assay
Approximately 1.5610 5 NIH3T3 cells were plated onto a 100 mm culture dish and DNA transfection was performed by the standard calcium phosphate precipitation method (Wigler et al., 1977) . In all cases, the amount of DNA added was normalized by the addition of control expression vector, pCEV29-lacZ. After transfection, cells were medium-changed twice a week with 5% CS in DMEM and the number and quality of foci were scored every week for up to 3 weeks. All plates were then ®xed in 75% cold methanol and stained with Giemsa solution.
Mitogenicity assay
Approximately 1610 4 cells were plated per well onto a 96-well plate (Costar) in triplicate coated with ®bronectin (10 mg ml 71 ). Twenty-four hours after plating, cells were maintained in low serum (3% CS) for 6 h and then treated without or with varying amounts (3.0, 9.0 and 27.0 mg ml 71 ) of C3 transferase (List Biologicals, CA) for 60 h. Cells were then pulse-labeled with [
3 H]thymidine (5 mCi ml 71 , NEN) for 6 h at 378C. The amount of tritiated thymidine incorporated was precipitated with 5% trichloroacetic acid (TCA) and solubilized in 150 ml of 0.25 N sodium hydroxide (NaOH). 50 ml aliquots of the reactions were then counted in a scintillation counter.
Kinase assay
For transient assays, 1610 6 COS7 cells were transfected singly or doubly with the appropriate amount of each plasmid (Coso et al., 1995) . The JNK/SAPK was exogenously introduced by transfecting 2.0 mg of an HAepitopetagged JNK/SAPK expression plasmid, pCDNAIII-HA-JNK. Positive control was provided by a constitutively active MEKK1 expression plasmid, pCEV29-MEKKE1, which is an upstream activator of JNK/SAPK (Cano and Mahadevan 1994; Kyriakis et al., 1994) and stimulates JNK/SAPK activity by *10 ± 20-fold. One day after transfection, cells were placed in serum-depleted medium for 2 h and then lysed in 25 mM HEPES (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1% Triton X-100, 0.5 mM DTT, 20 mM b-glycerophosphate, 0.1 mM Na 3 VO 4 , 2 mg ml 71 leupeptin, 100 mg ml 71 PMSF, 0.1% SDS and 0.5% sodium deoxycholate. Exogenously expressed HA-JNK was immunoprecipitated from total cell lysates with 1.0 mg of an anti-HA monoclonal antibody, followed by coupling to 30 ml of g-bind G-sepharose (Pharmacia). Immune complexes were washed three times with 1% NP-40 and 2 mM Na 3 VO 4 in PBS, followed by one wash in 0.5 mM LiCl and 100 mM Tris (pH 7.5). Beads were then resuspended in 30 ml of a kinase reaction buer (12.5 mM HEPES pH 7.5, 12.5 mM b-glycerophosphate, 7.5 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM NaF, 0.5 mM Na 3 VO 4 , 1.0 mCi of [g 32 P]ATP, 20 mM cold ATP, 3.3 mM DTT and 2.0 mg of GST-Jun79 fusion protein) and incubated at 308C for 30 min. Reactions were stopped with the addition of 10 ml of 46Lammeli loading buer and 10 ml were resolved on a 12.5% SDS ± PAGE gel. Dried gels were then exposed to X-ray ®lm. The GSTJun79 could be identi®ed as a discrete 32 P-labeled species of 38 kDa.
Transcription reporter assay
The SRE reporter construct was synthesized with an oligonucleotide adaptor with three tandemly positioned SRE sequence [GCTAGC(CCATATTAGG) 3 AGATCT] and inserted into the NheI and BglII sites of a backbone reporter vector, pGL-2 (Promega) with a fos minimal promoter and the downstream reporter gene, luciferase . Transient transfection of NIH3T3 cells was carried out in duplicate with 5610 5 cells per 60 mm culture dish using 2.0 mg of the reporter plasmid and 2.0 mg of each expression vector. The total amount of DNA (*6 mg) per plate was made constant by the addition of the control plasmid, pCEV29. Twenty-four hours after transfection, cultures were maintained in low serum (0.5% CS) for 24 h. Cells were solubilized in 250 ml of reporter lysis buer (Promega) and 20 ml of this extract were added to 100 ml of luciferase substrate (Promega); emitted light was measured in duplicate using a luminometer. The data were normalized for the amount of protein and expressed as arbitrary luminescence unit per mg of total protein.
